Dementia Prevention Is Becoming Less About Supplements and More About Systems
Nearly half of dementia risk may be modifiable
The World Health Organization’s updated dementia-prevention guidance delivers a remarkably practical message: protecting the brain is largely an extension of protecting the heart, maintaining sensory function, staying physically and socially active, and reducing harmful exposures.
What it does not endorse is equally important. Omega-3 supplements, multivitamins, and vitamins B or E should not be taken specifically to prevent cognitive decline or dementia when no nutritional deficiency has been diagnosed.
That distinction matters in a market crowded with supplements promising “brain health” while many of the interventions supported by evidence remain decidedly unglamorous.
Nearly half of dementia risk may be modifiable
More than 57 million people worldwide live with dementia, with nearly 10 million new cases diagnosed each year. Alzheimer’s disease accounts for an estimated 60% to 70% of cases.
The WHO guidance builds on a growing body of evidence suggesting that as much as 45% of dementia risk may be associated with potentially modifiable factors. These include smoking, excessive alcohol use, physical inactivity, social isolation, air pollution, hearing loss, hypertension, diabetes, and high cholesterol.
This does not mean 45% of dementia cases can be reliably prevented in every population. Nor does it mean someone who develops dementia failed to live correctly. Genetics, aging, socioeconomic conditions, and factors that medicine does not yet understand remain important.
But it does mean dementia is no longer something we should view only as an unavoidable consequence of aging.
What the WHO recommends
The updated guidance applies to adults with normal cognition as well as those with mild cognitive impairment. Its recommendations emphasize several overlapping areas:
Regular physical activity
Tobacco cessation
Reduced harmful alcohol consumption
A healthy dietary pattern
Cognitive training and stimulation
Continued social engagement
Management of hypertension, diabetes, and high cholesterol
Treatment of hearing loss when appropriate
Reduced exposure to air pollution
Weight-management interventions for adults with overweight or obesity
Tailored programs addressing several risk factors together
The multidomain approach may be the most important part. Dementia rarely results from one isolated exposure, and meaningful prevention probably will not come from one pill, one food, or one mental exercise.
A person who exercises but leaves hypertension untreated may still carry substantial risk. Someone who controls glucose but becomes socially isolated and stops treating hearing loss may lose some of that advantage. Brain health reflects the cumulative effects of several systems over decades.
The supplement message is unusually clear
The WHO does not recommend omega-3 fatty acids, multivitamin-mineral supplements, or vitamins B and E specifically for preventing dementia or cognitive decline in people without a diagnosed deficiency.
That does not mean these nutrients are biologically unimportant. A deficiency should still be identified and treated. The guidance instead says that taking additional supplements in the absence of deficiency has not produced sufficiently convincing preventive benefits.
This is a useful example of the difference between biological plausibility and demonstrated clinical benefit. A nutrient may participate in normal brain function without supplementation preventing dementia in an adequately nourished person.
Consumers are often sold the first claim as though it proves the second.
Hormone therapy is not a dementia-prevention treatment
The guidelines also advise against using menopausal hormone therapy specifically to reduce dementia risk in women aged 65 and older. The certainty of evidence behind this recommendation is described as very low.
For women younger than 65, the WHO found insufficient evidence to make a determination. This should not be interpreted as a blanket judgment on hormone therapy for menopausal symptoms, bone health, or other clinical indications. It means hormone therapy should not be prescribed principally as a dementia-prevention strategy based on current evidence.
What about sleep and depression?
The WHO concluded that evidence was insufficient to make dementia-prevention recommendations specifically around improving sleep or treating depression.
That does not mean sleep and depression are irrelevant to health or that they should go untreated. Both can substantially affect memory, attention, daily functioning, cardiovascular health, and quality of life.
It means something narrower: researchers have not yet established with enough certainty that improving these conditions directly reduces the future incidence of dementia.
Absence of sufficient evidence is not evidence of absence.
Hearing care deserves more attention
Hearing loss is one of the most actionable and frequently overlooked dementia-risk factors. It can increase cognitive load, reduce communication, and contribute to social withdrawal.
Hearing aids are not guaranteed to prevent dementia, but treating hearing loss may improve communication, independence, and social participation immediately. Even if the long-term cognitive benefit varies between individuals, those near-term gains make hearing evaluation worthwhile.
This illustrates a broader principle behind the guidelines: many dementia-risk interventions improve life well before any possible effect on dementia becomes measurable.
The real prescription is long-term risk management
There is no supplement capable of replacing exercise, blood-pressure control, diabetes management, hearing treatment, social connection, and tobacco avoidance.
The updated guidance therefore reframes dementia prevention as a decades-long public-health and primary-care project. It begins before memory problems appear and requires participation from healthcare systems, communities, urban planners, families, and individuals.
The message is less exciting than a breakthrough capsule, but more useful: the most credible strategy for protecting the aging brain is to consistently protect the body and preserve engagement with the world.



This is such an important conversation as it challenges the assumption that dementia prevention is simply a matter of telling people to “live healthier.” The reality is far more complex: dementia risk reflects the interaction of vascular health, metabolic function, sleep, hearing and vision, education, social connection, genetics, and many other factors across the life course.
As a physician-scientist, I think one of the biggest opportunities is to move from a late-stage, disease-focused model toward earlier risk identification and individualized prevention. The same intervention will not have the same impact for everyone, and the biological pathways contributing to cognitive decline can differ substantially between individuals.
At the same time, we should be careful not to turn prevention into an impossible checklist or imply that individuals are solely responsible for their cognitive aging. Public health, socioeconomic conditions, access to care, and environmental exposures all shape the risk landscape.
The most promising future may be one where prevention becomes more precise: identifying which risk factors are most relevant for which person, and intervening early enough that we are not simply trying to treat dementia after the biology is already well established.
Thank you!